Ophthalmic compositions for treating ocular hypertension

Details for Australian Patent Application No. 2005274972 (hide)

Owner Merck & Co., Inc.

Inventors Shen, Dong-Ming; Doherty, James B.

Agent Spruson & Ferguson

Pub. Number AU-A-2005274972

PCT Pub. Number WO2006/020003

Priority 60/589,444 20.07.04 US

Filing date 15 July 2005

Wipo publication date 23 February 2006

International Classifications

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/020003 Priority application(s): WO2006/020003

10 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274973-Histone deacetylase inhibitors

2005274969-Use of Fischer-Tropsch condensate as a lean oil for heavy ends recovery from Fischer-Tropsch tail gas